» Articles » PMID: 38205329

Circular RNAs: Potential Biomarkers and Therapeutic Targets for Autoimmune Diseases

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Jan 11
PMID 38205329
Authors
Affiliations
Soon will be listed here.
Abstract

The outcomes and prognosis of autoimmune diseases depend on early diagnosis and effective treatments. However, symptoms of early autoimmune diseases are often remarkably similar to many inflammatory diseases, leading to difficulty in precise diagnosis. Circular RNAs (circRNAs) belong to a novel class of endogenous RNAs, functioning as microRNA (miRNA) sponges or participating in protein coding. It has been shown in many studies that patients with autoimmune diseases have aberrant circRNA expression in liquid biopsy samples (such as plasma, saliva, and urine). Thus, circRNAs are potential biomarkers for the diagnosis and prognosis of autoimmune diseases. Moreover, overexpression and depletion of target circRNAs can be utilized as possible therapeutic approaches for treating autoimmune diseases. In this review, we summarized recent progress in the roles of circRNAs in the pathogenesis of autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and type 1 diabetes. We also discussed their potential as biomarkers and therapeutic targets.

Citing Articles

The therapeutic potential of circular RNAs.

OLeary E, Jiang Y, Kristensen L, Hansen T, Kjems J Nat Rev Genet. 2025; .

PMID: 39789148 DOI: 10.1038/s41576-024-00806-x.


Importance of Studying Non-Coding RNA in Children and Adolescents with Type 1 Diabetes.

Cabiati M, Federico G, Del Ry S Biomedicines. 2024; 12(9).

PMID: 39335501 PMC: 11429055. DOI: 10.3390/biomedicines12091988.


Exploring the Roles of m6A-Modified circRNAs in Myasthenia Gravis Based on Multi-Omics Analysis.

Li S, Zhang Y, Liu G, Song N, Ruan Z, Guo R Mol Neurobiol. 2024; 62(2):1694-1704.

PMID: 39017976 DOI: 10.1007/s12035-024-04352-9.


The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.

Pathania A, Chava H, Balusu R, Pasupulati A, Coulter D, Challagundla K Mol Ther Oncol. 2024; 32(2):200785.

PMID: 38595981 PMC: 10973673. DOI: 10.1016/j.omton.2024.200785.

References
1.
Cardamone G, Paraboschi E, Solda G, Cantoni C, Supino D, Piccio L . Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis. Hum Mol Genet. 2018; 28(9):1414-1428. DOI: 10.1093/hmg/ddy438. View

2.
Cardamone G, Paraboschi E, Rimoldi V, Duga S, Solda G, Asselta R . The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis. Int J Mol Sci. 2017; 18(3). PMC: 5372592. DOI: 10.3390/ijms18030576. View

3.
Zhang J, Zhang Y, Ma Y, Luo L, Chu M, Zhang Z . Therapeutic Potential of Exosomal circRNA Derived from Synovial Mesenchymal Cells via Targeting circEDIL3/miR-485-3p/PIAS3/STAT3/VEGF Functional Module in Rheumatoid Arthritis. Int J Nanomedicine. 2021; 16:7977-7994. PMC: 8651050. DOI: 10.2147/IJN.S333465. View

4.
Tang M, Kui L, Lu G, Chen W . Disease-Associated Circular RNAs: From Biology to Computational Identification. Biomed Res Int. 2020; 2020:6798590. PMC: 7450300. DOI: 10.1155/2020/6798590. View

5.
Hansen T, Jensen T, Clausen B, Bramsen J, Finsen B, Damgaard C . Natural RNA circles function as efficient microRNA sponges. Nature. 2013; 495(7441):384-8. DOI: 10.1038/nature11993. View